Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Capital Expenditures (2017 - 2020)

enVVeno Medical has reported Capital Expenditures over the past 4 years, most recently at $27540.0 for Q4 2020.

  • Quarterly results put Capital Expenditures at $27540.0 for Q4 2020, up 112.55% from a year ago — trailing twelve months through Dec 2020 was $180291.0 (down 50.45% YoY), and the annual figure for FY2025 was $5000.0, down 86.49%.
  • Capital Expenditures for Q4 2020 was $27540.0 at enVVeno Medical, up from $24965.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for NVNO hit a ceiling of $177230.0 in Q2 2019 and a floor of $1800.0 in Q1 2019.
  • Median Capital Expenditures over the past 4 years was $18961.0 (2019), compared with a mean of $55695.8.
  • Biggest five-year swings in Capital Expenditures: soared 215.79% in 2019 and later crashed 85.48% in 2020.
  • enVVeno Medical's Capital Expenditures stood at $8673.0 in 2017, then plummeted by 52.69% to $4103.0 in 2018, then soared by 215.79% to $12957.0 in 2019, then soared by 112.55% to $27540.0 in 2020.
  • The last three reported values for Capital Expenditures were $27540.0 (Q4 2020), $24965.0 (Q3 2020), and $122473.0 (Q2 2020) per Business Quant data.